. . . because action speaks louder than words.
League history, NOW v. Scheidler, Action News, Joe Scheidler, League staff
Q & A on abortion, the unborn child, where we stand on the issues and more
Helping abortion-bound women choose life for their babies
Unmasking the truth about abortion in the public square
Our youth outreach, raising up a new generation of pro-life leaders
Abortion industry converts tell the inside story
News and commentary from the Pro-Life Action League
News and commentary from the Pro-Life Action League
Eric Scheidler’s post earlier this week shone a spotlight on Planned Parenthood’s failure to reduce unintended pregnancy in the U.S., despite receiving ever increasing taxpayer funding.
Following on his commentary, I thought it would be worth taking a closer look at another element of the seemingly endless “How can we reduce unintended pregnancy?” debate: namely, so-called emergency contraception (hereafter: EC).
Today I came across a press release dated September 2, 1998 from a company called Gynétics (which at the time was based in New Jersey, but is now based in Belgium). The release announced that the their product, Preven, had just become the “first FDA-approved product for emergency contraception that can prevent pregnancy when used within 72 hours” after sex.
The press release contained this comment from one Dr. Anita Nelson, an Ob/Gyn professor at UCLA:
It is estimated that nearly 50 percent of all abortions and unintended pregnancies in this country could be avoided if women had access to emergency contraception.
That’s no small prediction. And looking back, it’s turned out to be hopelessly wrong. [Continue reading ...]
One of several new images the FDA will require cigarette manufacturers to feature on their packaging soon.
The FDA is currently in the process of choosing nine graphic images depicting the results of smoking that it will require cigarette manufacturers to feature prominently on their packaging to deter people from smoking.
We at the League find this development very interesting given our use of graphic images of the victims of abortion in our Face the Truth campaigns to alter public opinion on the abortion issue. Graphic images show the true, stomach-churning face of abortion like nothing else can, so it’s easy to see where the FDA is coming from with this campaign. [Continue reading ...]
Although the FDA last week approved the drug “ella” (ulipristal acetate) for prescription use, the controversy over how it works — Is it a contraceptive, or an abortifacient, or both? — shows no signs of going away any time soon.
According to the New York Times, the members of the FDA’s advisory committee that voted to approve it were largely indifferent to this question; all they concluded, in their wisdom, is that it’s supposedly “safe and effective”.
Meanwhile, ella’s manufacturers are going to great lengths to claim that it functions only as a contraceptive and not as an abortifacient. Witness David Archer, whom Slate calls an “expert” for ella’s manufacturer, HRA Pharma of Paris: [Continue reading ...]